Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation

Microbes and Infection

Volumn 15, Issue 4, 2013, Pages 259-269

  Shepardson, Kelly M ^a,e   Ngo, Lisa Y ^b   Aimanianda, Vishukumar ^c   Latgé, Jean Paul ^c   Barker, Bridget M ^a   Blosser, Sara J ^a   Iwakura, Yoichiro ^d   Hohl, Tobias M ^b   Cramer, Robert A ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c INSTITUT PASTEUR   (France)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Aspergillus fumigatus; Beta glucan; Cell wall; Fungal pathogenesis; Hypoxia

Indexed keywords

BETA GLUCAN; CORTICOSTEROID; DECTIN 1;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CYTOKINE PRODUCTION; FUNGAL CELL WALL; HYPHEN WALL; HYPOXIA; IMMUNOMODULATION; INNATE IMMUNITY; LUNG ASPERGILLOSIS; MACROPHAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; THICKNESS;

ANAEROBIOSIS; ANIMALS; ASPERGILLUS FUMIGATUS; BETA-GLUCANS; CELL WALL; CYTOKINES; DISEASE MODELS, ANIMAL; HYPHAE; IMMUNITY, INNATE; LECTINS, C-TYPE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PULMONARY ASPERGILLOSIS;

ASPERGILLUS FUMIGATUS; MAMMALIA;

EID: 84876096010     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.11.010     Document Type: Article

References (50)

1. Segal B.H. Aspergillosis. N. Engl. J. Med. 2009, 360:1870-1884.
2. Upton A., Kirby K.A., Carpenter P., Boeckh M., Marr K.A. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin. Infect. Dis. 2007, 44:531-540.
3. Howard S.J., Arendrup M.C. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med. Mycol. 2011, 49(Suppl. 1):S90-S95.
4. Erjavec Z., Kluin-Nelemans H., Verweij P.E. Trends in invasive fungal infections, with emphasis on invasive aspergillosis. Clin. Microbiol. Infect. 2009, 15:625-633.
5. Bok J.W., Keller N.P., Tsitsigiannis D.I. Real-time and semiquantitative RT-PCR methods to analyze gene expression patterns during Aspergillus-host interactions. Methods Mol. Biol. 2009, 470:151-167.
6. Cooney N.M., Klein B.S. Fungal adaptation to the mammalian host: it is a new world, after all. Curr. Opin. Microbiol. 2008, 11:511-516.
7. Hartmann T., Sasse C., Schedler A., Hasenberg M., Gunzer M., Krappmann S. Shaping the fungal adaptome - stress responses of Aspergillus fumigatus. Int. J. Med. Microbiol. 2011, 301:408-416.
8. Shapiro R.S., Robbins N., Cowen L.E. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 2011, 75:213-267.
9. Bhabhra R., Askew D.S. Thermotolerance and virulence of Aspergillus fumigatus: role of the fungal nucleolus. Med. Mycol. 2005, 43(Suppl. 1):S87-S93.
10. Grahl N., Puttikamonkul S., Macdonald J.M., Gamcsik M.P., Ngo L.Y., Hohl T.M., Cramer R.A. In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis. PLoS Pathog. 2011, 7:e1002145.
11. Willger S.D., Puttikamonkul S., Kim K.H., Burritt J.B., Grahl N., Metzler L.J., Barbuch R., Bard M., Lawrence C.B., Cramer R.A. A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog. 2008, 4:e1000200.
12. Blatzer M., Barker B.M., Willger S.D., Beckmann N., Blosser S.J., Cornish E.J., Mazurie A., Grahl N., Haas H., Cramer R.A. SREBP coordinates iron and ergosterol homeostasis to mediate triazole drug and hypoxia responses in the human fungal pathogen Aspergillus fumigatus. PLoS Genet. 2011, 7:e1002374.
13. Latge J.P. The cell wall: a carbohydrate armour for the fungal cell. Mol. Microbiol. 2007, 66:279-290.
14. Latge J.P. Tasting the fungal cell wall. Cell. Microbiol. 2010, 12:863-872.
15. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
16. Fontaine T., Delangle A., Simenel C., Coddeville B., van Vliet S.J., van Kooyk Y., Bozza S., Moretti S., Schwarz F., Trichot C., Aebi M., Delepierre M., Elbim C., Romani L., Latge J.P. Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus. PLoS Pathog. 2011, 7:e1002372.
17. Abramova N., Sertil O., Mehta S., Lowry C.V. Reciprocal regulation of anaerobic and aerobic cell wall mannoprotein gene expression in Saccharomyces cerevisiae. J. Bacteriol. 2001, 183:2881-2887.
18. Barker B.M., Kroll K., Vodisch M., Mazurie A., Kniemeyer O., Cramer R.A. Transcriptomic and proteomic analyses of the Aspergillus fumigatus hypoxia response using an oxygen-controlled fermenter. BMC Genom. 2012, 13:62.
19. Gastebois A., Clavaud C., Aimanianda V., Latge J.P. Aspergillus fumigatus: cell wall polysaccharides, their biosynthesis and organization. Future Microbiol. 2009, 4:583-595.
20. Gibbons J.G., Beauvais A., Beau R., McGary K.L., Latge J.P., Rokas A. Global transcriptome changes underlying colony growth in the opportunistic human pathogen Aspergillus fumigatus. Eukaryot. Cell 2012, 11:68-78.
21. Mellado E., Dubreucq G., Mol P., Sarfati J., Paris S., Diaquin M., Holden D.W., Rodriguez-Tudela J.L., Latge J.P. Cell wall biogenesis in a double chitin synthase mutant (chsG-/chsE-) of Aspergillus fumigatus. Fungal Genet. Biol. 2003, 38:98-109.
22. Sosinska G.J., de Groot P.W., Teixeira de Mattos M.J., Dekker H.L., de Koster C.G., Hellingwerf K.J., Klis F.M. Hypoxic conditions and iron restriction affect the cell-wall proteome of Candida albicans grown under vagina-simulative conditions. Microbiology 2008, 154:510-520.
23. Zitomer R.S., Carrico P., Deckert J. Regulation of hypoxic gene expression in yeast. Kidney Int. 1997, 51:507-513.
24. Zhao L., Schaefer D., Xu H., Modi S.J., LaCourse W.R., Marten M.R. Elastic properties of the cell wall of Aspergillus nidulans studied with atomic force microscopy. Biotechnol. Prog. 2005, 21:292-299.
25. Hohl T.M., Feldmesser M., Perlin D.S., Pamer E.G. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J. Infect. Dis. 2008, 198:176-185.
26. Lamaris G.A., Lewis R.E., Chamilos G., May G.S., Safdar A., Walsh T.J., Raad I.I., Kontoyiannis D.P. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J. Infect. Dis. 2008, 198:186-192.
27. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., Wong S.Y., Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 2002, 196:407-412.
28. Dennehy K.M., Brown G.D. The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J. Leukoc. Biol. 2007, 82:253-258.
29. Barber D.L., Mayer-Barber K.D., Antonelli L.R., Wilson M.S., White S., Caspar P., Hieny S., Sereti I., Sher A. Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 2010, 116:3485-3493.
30. Gupta A.O., Singh N. Immune reconstitution syndrome and fungal infections. Curr. Opin. Infect. Dis. 2011, 24:527-533.
31. Miceli M.H., Maertens J., Buve K., Grazziutti M., Woods G., Rahman M., Barlogie B., Anaissie E.J. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer 2007, 110:112-120.
32. Graham L.M., Tsoni S.V., Willment J.A., Williams D.L., Taylor P.R., Gordon S., Dennehy K., Brown G.D. Soluble Dectin-1 as a tool to detect beta-glucans. J. Immunol. Methods 2006, 314:164-169.
33. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
34. Richie D.L., Hartl L., Aimanianda V., Winters M.S., Fuller K.K., Miley M.D., White S., McCarthy J.W., Latge J.P., Feldmesser M., Rhodes J.C., Askew D.S. A role for the unfolded protein response (UPR) in virulence and antifungal susceptibility in Aspergillus fumigatus. PLoS Pathog. 2009, 5:e1000258.
35. Meletiadis J., Mouton J.W., Meis J.F., Bouman B.A., Donnelly J.P., Verweij P.E. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 2001, 39:3402-3408.
36. Meshulam T., Levitz S.M., Christin L., Diamond R.D. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanilide (XTT). J. Infect. Dis. 1995, 172:1153-1156.
37. Voyich J.M., Braughton K.R., Sturdevant D.E., Whitney A.R., Said-Salim B., Porcella S.F., Long R.D., Dorward D.W., Gardner D.J., Kreiswirth B.N., Musser J.M., DeLeo F.R. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 2005, 175:3907-3919.
38. Steinbach W.J., Benjamin D.K., Trasi S.A., Miller J.L., Schell W.A., Zaas A.K., Foster W.M., Perfect J.R. Value of an inhalational model of invasive aspergillosis. Med. Mycol. 2004, 42:417-425.
39. Ariizumi K., Shen G.L., Shikano S., Xu S., Ritter R., Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 2000, 275:20157-20167.
40. Hohl T.M., Van Epps H.L., Rivera A., Morgan L.A., Chen P.L., Feldmesser M., Pamer E.G. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 2005, 1:e30.
41. Steele C., Rapaka R.R., Metz A., Pop S.M., Williams D.L., Gordon S., Kolls J.K., Brown G.D. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 2005, 1:e42.
42. Raleigh J.A., Franko A.J., Koch C.J., Born J.L. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label. Br. J. Cancer 1985, 51:229-235.
43. Raleigh J.A., Calkins-Adams D.P., Rinker L.H., Ballenger C.A., Weissler M.C., Fowler W.C., Novotny D.B., Varia M.A. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res. 1998, 58:3765-3768.
44. Ljungkvist A.S., Bussink J., Rijken P.F., Raleigh J.A., Denekamp J., Van Der Kogel A.J. Changes in tumor hypoxia measured with a double hypoxic marker technique. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48:1529-1538.
45. Arteel G.E., Thurman R.G., Raleigh J.A. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur. J. Biochem. 1998, 253:743-750.
46. Wheeler R.T., Kombe D., Agarwala S.D., Fink G.R. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog. 2008, 4:e1000227.
47. Lewis R.E., Kontoyiannis D.P. Invasive aspergillosis in glucocorticoid-treated patients. Med. Mycol. 2009, 47(Suppl. 1):S271-S281.
48. Balloy V., Huerre M., Latge J.P., Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect. Immun. 2005, 73:494-503.
49. Chai L.Y., Vonk A.G., Kullberg B.J., Verweij P.E., Verschueren I., van der Meer J.W., Joosten L.A., Latge J.P., Netea M.G. Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses. Microbe. Infect. 2011, 13:151-159.
50. Mora-Montes H.M., Netea M.G., Ferwerda G., Lenardon M.D., Brown G.D., Mistry A.R., Kullberg B.J., O'Callaghan C.A., Sheth C.C., Odds F.C., Brown A.J., Munro C.A., Gow N.A. Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect. Immun. 2011, 79:1961-1970.